Phosphorylation of 4E-BP1 in the Mammalian Brain Is Not Altered by LRRK2 Expression or Pathogenic Mutations
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are a common cause of autosomal dominant familial Parkinson's disease (PD). LRRK2 encodes a multi-domain protein containing GTPase and kinase enzymatic domains. Disease-associated mutations in LRRK2 variably influence enzymatic activity with the common G2019S variant leading to enhanced kinase activity. Mutant LRRK2 induces neuronal toxicity through a kinase-dependent mechanism suggesting that kinase activity is important for mediating the pathogenic effects of LRRK2 mutations. A number of LRRK2 kinase substrates have been identified in vitro but whether they represent authentic physiological substrates in mammalian cells or tissues is not yet clear. The eukaryotic initiation factor 4E (eIF4E)-binding protein, 4E-BP1, was recently identified as a potential substrate of LRRK2 kinase activity in vitro and in Drosophila with phosphorylation occurring at Thr37 and Thr46. Here, we explore a potential interaction of LRRK2 and 4E-BP1 in mammalian cells and brain. We find that LRRK2 can weakly phosphorylate 4E-BP1 in vitro but LRRK2 overexpression is not able to alter endogenous 4E-BP1 phosphorylation in mammalian cells. In mammalian neurons LRRK2 and 4E-BP1 display minimal co-localization, whereas the subcellular distribution, protein complex formation and covalent post-translational modification of endogenous 4E-BP1 are not altered in the brains of LRRK2 knockout or mutant LRRK2 transgenic mice. In the brain, the phosphorylation of 4E-BP1 at Thr37 and Thr46 does not change in LRRK2 knockout or mutant LRRK2 transgenic mice, nor is 4E-BP1 phosphorylation altered in idiopathic or G2019S mutant PD brains. Collectively, our results suggest that 4E-BP1 is neither a major nor robust physiological substrate of LRRK2 in mammalian cells or brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
West, A. B., Moore, D. J., Biskup, S., Bugayenko, A., Smith, W. W., Ross, C. A., Dawson, V. L., & Dawson, T. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507360102 · Cited by 1,228 · cited 3×
“Mutations alter enzymatic activities that include enhanced kinase activity (i.e. G2019S and N1437H) [10,11,12], reduced GTPase activity (i.e. R1441C/G/H and Y1699C) [13,14,15,16] or enhanced GTP-binding (i.e. N1437H, R1441C/G/H and Y1699C) [17] of LRRK2.”
Self-citationKinase activity of mutant LRRK2 mediates neuronal toxicity
Smith, W. W., Pei, Z., Jiang, H., Dawson, V. L., Dawson, T. M., & Ross, C. A. (2006) · Nature Neuroscience · doi:10.1038/nn1776 · Cited by 619 · cited 1×
“LRRK2 mutations have also been shown to enhance neuronal toxicity compared to the wild-type (WT) protein through a mechanism dependent on kinase and/or GTPase activity [17,18,19,20].”
BackgroundRamonet, D., Daher, J. P. L., Lin, B. M., Stafa, K., Kim, J., Banerjee, R., Westerlund, M., Pletnikova, O., Glauser, L., Yang, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018568 · Cited by 405 · cited 2×
“In this context, one could speculate that LRRK2-dependent 4E-BP1 phosphorylation may occur in aging flies due to inherent stress, as reflected by the increased sensitivity of dLRRK transgenic flies exposed to oxidative insult [25], whereas the LRRK2 knockout and transgenic mice at the ages used in this study do not de…”
BackgroundSelf-citationRapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss
Tain, L. S., Mortiboys, H., Tao, R. N., Ziviani, E., Bandmann, O., & Whitworth, A. J. (2009) · Nature Neuroscience · doi:10.1038/nn.2372 · Cited by 323
Parkin promotes the ubiquitination and degradation of the mitochondrial fusion factor mitofusin 1
Glauser, L., Sonnay, S., Stafa, K., & Moore, D. J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07318.x · Cited by 230 · cited 8×
“A D1994A mutation was introduced into FLAG-tagged WT LRRK2 by PCR-mediated site-directed mutagenesis using the QuickChange II XL kit (Agilent Technologies, La Jolla, CA, USA) and verified by DNA sequencing.”
MethodInfluentialSelf-citation
Cited by
Ribosomal Protein s15 Phosphorylation Mediates LRRK2 Neurodegeneration in Parkinson’s Disease
Martin, I., Kim, J. W., Lee, B. D., Kang, H. C., Xu, J.-C., Jia, H., Stankowski, J., Kim, M.-S., Zhong, J., Kumar, M., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.064 · Cited by 265
“…binding proteins such as TAR DNA binding protein-43 (TDP-43) and fused in sarcoma/translocated in sarcoma (FUS/TLS) has been implicated in the pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia (Lagier-Tourenne et al., 2012; Polymenidou et al., 2011; Tollervey et al., 2011).”
BackgroundParkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration
Tsika, E., Glauser, L., Moser, R., Fiser, A., Daniel, G., Sheerin, U.-M., Lees, A., Troncoso, J. C., Lewis, P. A., Bandopadhyay, R., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu178 · Cited by 159
“…analysis, caudate putamen tissue derived from five normal control and seven PD/DLB sub-jectswasobtainedfromJHMI(Table1),andfrontalcortextissue derivedfromfournormalcontrolandeightPDsubjectswas obtainedfromthearchiveatQueenSquareBrainBank (QSBB)aspreviouslyreported(35)andindicatedinTable2.”
MethodSelf-citationBeccano-Kelly, D. A., Kuhlmann, N., Tatarnikov, I., Volta, M., Munsie, L. N., Chou, P., Cao, L.-P., Han, H., Tapia, L., Farrer, M. J., et al. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00301 · Cited by 97
Decoding Parkinson’s Disease Pathogenesis: The Role of Deregulated mRNA Translation
Martin, I. (2016) · Journal of Parkinson’s Disease · doi:10.3233/jpd-150738 · Cited by 23
“Contrastingly, in LRRK2transfected HEK cells or mammalian brain, 4E-BP1 does not appear to be a direct LRRK2 substrate [40, 55] and increased phosphorylation of 4E-BP1 is not found in G2019S LRRK2 knock-in mice but, conversely has been reported in LRRK2 knockout mice and LRRK2 kinase-dead transgenic mice [56].”
Background
Metadata
- Authors
- Trancikova, A., Mamais, A., Webber, P. J., Stafa, K., Tsika, E., Glauser, L., West, A. B., Bandopadhyay, R., & Moore, D. J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-10-17
- Volume
- 7
- Issue
- 10
- Pages
- e47784
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2115561747
- Cited by
- 43
- References
- 5
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phosphorylation of 4E-BP1 in the Mammalian Brain Is Not Altered by LRRK2 Expression or Pathogenic Mutations. https://app.cochat.ai/papers/10.1371/journal.pone.0047784
- The paper
- Trancikova, A., Mamais, A., Webber, P. J., Stafa, K., Tsika, E., Glauser, L., West, A. B., Bandopadhyay, R., & Moore, D. J. (2012). Phosphorylation of 4E-BP1 in the Mammalian Brain Is Not Altered by LRRK2 Expression or Pathogenic Mutations. PLoS ONE. https://doi.org/10.1371/journal.pone.0047784
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.